Veterinary Infectious Disease Diagnostics Market Report 2025

This Veterinary Infectious Disease Diagnostics report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The veterinary infectious disease diagnostics market size has grown strongly in recent years. It will grow from $1.93 billion in 2024 to $2.11 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increasing pet ownership, advancements in veterinary medicine, humanization of pets, regulatory support.

The veterinary infectious disease diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.07 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to emerging diseases, increased research and development, globalization of veterinary practices, and growing livestock population. Major trends in the forecast period include technological innovations, rapid adoption of point-of-care testing, integration of molecular diagnostics, digitalization in veterinary healthcare, expansion of product portfolios, collaborations and partnerships, customized diagnostics for different animal species.

The rising incidence of transboundary and zoonotic diseases, such as rabies, is expected to drive the growth of the veterinary infectious disease diagnostics market in the future. Zoonoses are infections and diseases that are transmitted spontaneously between humans and vertebrate animals. Veterinary infectious disease diagnostics play a crucial role in detecting rabies in pets and animals, helping to prevent fatal outcomes. For example, in 2022, the World Health Organization (WHO), a Swiss-based government agency, reported that rabies was present in over 150 countries and territories. Dogs are the primary source of human rabies fatalities, accounting for nearly 99% of all rabies transmissions. Additionally, children under 15 years old represent 40% of those bitten by suspected rabid animals. Rabies infection results in tens of thousands of deaths each year, primarily in Asia and Africa. Therefore, the increasing prevalence of transboundary and zoonotic diseases is propelling the growth of the veterinary infectious disease diagnostics market.

The increasing rate of pet adoption is anticipated to drive the growth of the veterinary infectious disease diagnostics market in the coming years. There is a high demand for animal treatments and diagnostics as more individuals welcome pets into their families and become increasingly aware of and concerned about their health. Pet owners are willing to invest in medical care, regular check-ups, and preventive measures. For instance, in 2023, Shelter Animals Count, a US-based non-governmental organization, reported that dog adoptions rose by 109,000 compared to 2022, reflecting a positive trend in adoption rates. However, the total number of dogs adopted in 2023 is still approximately 108,000 lower than the previous year. Thus, the rising rate of pet adoption is fueling the veterinary infectious disease diagnostics market during the forecast period.

Technological advancements have emerged as a prominent trend in the veterinary infectious disease diagnostics market, with major companies introducing innovative technologies to maintain their market positions. For example, Merck Animal Health launched SenseHub Feedlot, a technology-enabled solution based on electronic ear tag technology. This system swiftly detects illness, provides reliable disease diagnoses, and allows for early intervention to manage pain in cattle more effectively than traditional methods.

Major companies operating in the veterinary infectious disease diagnostics market are also intensifying their focus on developing and introducing drugs for multiple diseases. One such example is the drug Increxxa, approved for treating livestock respiratory disease. Elanco Animal Health Incorporated introduced Increxxa, featuring tulathromycin as the key ingredient, delivered via injection to swiftly target and act on lung infections in livestock. Tulathromycin helps mitigate the negative effects of bovine respiratory disease in animals. This strategic focus on drug development is aimed at gaining a competitive edge in the veterinary infectious disease diagnostics market.

In September 2022, Zoetis Inc., a prominent animal health company, acquired NewMetrica for an undisclosed amount. This acquisition enhances Zoetis's portfolio in pain management for animal diseases, strengthens quality-of-life assessment capabilities, and extends the reach of their animal diagnostic products to Europe. NewMetrica, a UK-based company, specializes in developing instruments and devices for pain management in animals.

Major companies operating in the veterinary infectious disease diagnostics market include Zoetis Inc., IDEXX Laboratories Inc., Thermo Fisher Scientific Inc., QIAGEN N. V., IDvet, NEOGEN Corporation, INDICAL BIOSCIENCE GmbH, Randox Laboratories Ltd, Creative Diagnostics, Heska Corporation, Chembio Diagnostics Inc., URIT Medical Electronic Co. Ltd., NTBIO Diagnostics Inc., Bio-X Diagnostics, Agrolabo Spa, Virbac, Covetrus Inc., Biomerieux S. A., Bio-Rad Laboratories Inc., Eurofins Scientific SE, Fujifilm Wako Pure Chemical Corporation, GenScript Biotech Corporation, Merck KGaA, MP Biomedicals LLC, Quidel Corporation, Roche Diagnostics Corporation, Siemens Healthineers AG, Sysmex Corporation, VCA Inc., Vetoquinol SA.

North America was the largest region in the veterinary disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary infectious disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary infectious disease diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

Veterinary infectious disease diagnostics refer to diagnostic services used for the identification of infectious diseases in animals, encompassing infectious diseases and factors impacting the health of livestock, domestic animals, and wildlife. These diagnostics have become essential for ensuring the overall well-being of animals by diagnosing infections in various animal types.

The primary types of veterinary infectious disease diagnostics include viral infections, bacterial infections, parasitic infections, and other infections. Bacterial infections can be transmitted from dogs to humans through dog bites, while other infections caused by protozoa typically have a fecal-oral transmission route. Different animals, such as companion animals and food-producing animals, are covered by these diagnostics, utilizing various technologies like immunodiagnostics, molecular diagnostics, and other diagnostic methods. These diagnostic services are utilized across different settings, including reference laboratories, veterinary hospitals and clinics, point of care facilities, research institutes and universities, and other end-user environments.

The veterinary infectious disease diagnostics market research report is one of a series of new reports that provides veterinary infectious disease diagnostics market statistics, including veterinary infectious disease diagnostics industry global market size, regional shares, competitors with a veterinary infectious disease diagnostics market share, detailed veterinary infectious disease diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary infectious disease diagnostics industry. This veterinary infectious disease diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary infectious disease diagnostics market includes revenues earned by entities by identifying and determining whether an animal has any viral, bacterial, parasitic, or other types of illnesses. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.